Similarly, in experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis (MS), Chabas et al. showed that anti-OPN antibodies mitigated demyelination and inflammation, suggesting a critical role of OPN in neuroinflammatory diseases [142]. This evidence concerns the gene SPP1 and multiple sclerosis.